[topsearch__bar__shortcode]

March 30, 2022

NAOV Flies High After Approval By Canadian Healthcare Regulators

NanoVibronix, Inc. (NASDAQ: NAOV) has been rising steadily in today’s session, soaring well above the $1 mark after two months. Having last surpassed the $1 domain in January, NAOV has been impressive to its investors throughout current-trade hours today. After tremendous after-hours and premarket climb, the stock is currently almost 40% above its previous close […]

NAOV Flies High After Approval By Canadian Healthcare Regulators Read More »

Crypto market Rallies Ahead of New Controversial EU Regulation

As the European Union associations are moving their discussions on the questionable Transfer of Funds Regulation (TFR), crypto industry specialists are expecting to hamper the recommendation’s potentially frightful impact on the area’s future new development. Among others, the rule could plan for a crackdown on claimed “unhosted wallets,” or just standard crypto wallets. Craftsmanship. 5

Crypto market Rallies Ahead of New Controversial EU Regulation Read More »

Chainlink Labs Hires Diem CTO

Chainlink Labs on Tuesday recruited previous Diem chief Dahlia Malkhi to assist with supporting the development of the information prophet organization. Malkhi becomes boss examination official following her spell as boss innovation official of the Diem Association, the Facebook-upheld stablecoin project that injury down recently. Chainlink is a data oracle network that conveys data like

Chainlink Labs Hires Diem CTO Read More »

AGRX Tumbles After a Brief Pre-Market Climb

Stock for Agile Therapeutics, Inc. (NASDAQ: AGRX) has been on a downward tumble after a brief rise in the pre-market hours. Seeing a climb of nearly 8% before today’s trade session commencement, the stock remains closely eyed by market participants. After the commencement of the trade session, AGRX had fallen nearly 10.5% in less than

AGRX Tumbles After a Brief Pre-Market Climb Read More »

ADGI Soars As Its Candidate Shows High Efficacy in Clinical Trials

Adagio Therapeutics, Inc. (NASDAQ: ADGI) following its inactive trade session yesterday, netting in a 1% gain, exploded in the premarket. Total growth for the stock continued upwards of 78%, pushing up its price to an impressive $6.68, earlier today. It has been on a persistent bearish slide since early February, losing a total of 47.55%

ADGI Soars As Its Candidate Shows High Efficacy in Clinical Trials Read More »

VYNT Goes Big Following Breakthrough Strategic Partnership

Following yesterday’s impressive 16.4% gain Vyant Bio, Inc. (NASDAQ: VYNT) further rushed up to a 51.1% climb by pre-market hours. This heavy growth spurt has caused a spur amongst the market, and especially amongst bulls, betting long positions on VYNT. This bullish trajectory traces back to late January, with the stock climbing an impressive 35%

VYNT Goes Big Following Breakthrough Strategic Partnership Read More »